Oxford Biomedica (OXB) News Today GBX 612 +3.00 (+0.49%) As of 08:20 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock OXB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Oxford Biomedica (LON:OXB) Stock Passes Above 200-Day Moving Average - Should You Sell?May 8, 2026 | marketbeat.comOxford Biomedica plc (LON:OXB) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesApril 30, 2026 | marketbeat.comHow I invested my first £1,000 in FTSE shares… and the mistakes I madeApril 25, 2026 | uk.finance.yahoo.comOxford Biomedica (LON:OXB) Share Price Passes Above 200-Day Moving Average - Here's WhyApril 22, 2026 | marketbeat.com57% under ‘fair value’ and 74% forecast earnings growth! 1 FTSE high-tech med stock I just can’t pass upApril 20, 2026 | uk.finance.yahoo.comOxford Biomedica unveils fast-track viral vector service to speed gene therapy developmentApril 14, 2026 | theglobeandmail.comOxford Biomedica Confirms Updated Total Voting RightsApril 11, 2026 | theglobeandmail.comOxford BioMedica PLC (LSE:OXB) Q4 2025 Earnings Report Preview: What To ExpectMarch 25, 2026 | finance.yahoo.comAn Intrinsic Calculation For Oxford Biomedica plc (LON:OXB) Suggests It's 47% UndervaluedJanuary 15, 2026 | finance.yahoo.comEQT in talks to take over Oxford BioMedicaJanuary 14, 2026 | ft.comOxford Biomedica Confirms Total Voting Rights at Year-EndJanuary 8, 2026 | theglobeandmail.comThe FTSE 250 stock that doubled my money in just 6 months!November 29, 2025 | msn.comUp 163%, what’s going on with this FTSE 250 biotech innovator’s share price?October 27, 2025 | msn.comOxford Biomedica (LON:OXB) Insider Heather Preston Purchases 6,175 SharesOctober 21, 2025 | insidertrades.comOXB acquires US manufacturing site, accelerating expansionOctober 7, 2025 | investing.comOxford Biomedica says existing financial guidance ‘remains unchanged’October 7, 2025 | msn.comOxford BioMedica narrows interim loss, backs annual outlookSeptember 23, 2025 | lse.co.ukOxford Biomedica beats revenue expectations, narrows losses in first halfSeptember 23, 2025 | za.investing.comDame Kay Davies Sells 4,563 Shares of Oxford Biomedica (LON:OXB) StockAugust 23, 2025 | insidertrades.comRoch Doliveux Purchases 67,000 Shares of Oxford Biomedica plc (LON:OXB) StockAugust 19, 2025 | insidertrades.comFrederic Doliveux Bought 18% More Shares In Oxford BiomedicaAugust 17, 2025 | finance.yahoo.comUK's Oxford Biomedica maintains annual outlookJuly 28, 2025 | reuters.comInsider Spends UK£37k Buying More Shares In Oxford BiomedicaJune 25, 2025 | finance.yahoo.comOxford Biomedica completes acquisition of remaining stake in U.S. subsidiaryJune 24, 2025 | finance.yahoo.comHeather Preston Acquires 11,389 Shares of Oxford Biomedica plc (LON:OXB) StockJune 18, 2025 | insidertrades.comOxford Biomedica announces executive share option grantsMay 17, 2025 | uk.investing.comOxford BioMedica PLC OXBMay 7, 2025 | morningstar.comMOxford Biomedica insider completes share transactionMay 2, 2025 | uk.investing.comOxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last yearApril 9, 2025 | msn.comOxford Biomedica falls on lower EBITDA outlook despite strong revenue guideApril 9, 2025 | investing.comViroCell Biologics Appoints Viral Vector Expert as Special AdvisorMarch 28, 2025 | finance.yahoo.comOXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' categoryMarch 21, 2025 | markets.businessinsider.comOxford Biomedica backs novel cystic fibrosis gene therapy trialFebruary 21, 2025 | investing.comBoehringer and partners commence gene therapy trial for cystic fibrosisFebruary 21, 2025 | msn.comBoehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosisFebruary 20, 2025 | markets.businessinsider.comNovel inhalable gene therapy trialed for people with cystic fibrosisFebruary 20, 2025 | msn.comSMALL-CAP WINNERS & LOSERS: Wilmington half-year profit fallsFebruary 17, 2025 | lse.co.ukOxford BioMedica shares fall as revenue to stay below 2022 levelFebruary 17, 2025 | lse.co.ukOxford Biomedica Share Chat (OXB)February 14, 2025 | lse.co.ukOxford Biomedica Strengthens Board with Key AppointmentNovember 18, 2024 | msn.comOxford Biomedica Announces Total Voting Rights UpdateNovember 1, 2024 | markets.businessinsider.comOxford BioMedica Sees Shift in Voting RightsOctober 31, 2024 | markets.businessinsider.comThis skyrocketing growth stock is up 100% this year! Is it too late to buy?October 23, 2024 | msn.comOxford BioMedica PLC (OXBDF) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue ...September 24, 2024 | finance.yahoo.comOxford Biomedica plc (OXBDF) Q2 2024 Earnings Call TranscriptSeptember 23, 2024 | seekingalpha.comPositive Signs As Multiple Insiders Buy Oxford Biomedica StockSeptember 16, 2024 | finance.yahoo.comOxford Biomedica to host a free webinar showcasing its AAV expertiseAugust 27, 2024 | uk.finance.yahoo.comOxford Biomedica Regulatory NewsAugust 12, 2024 | lse.co.ukOxford BioMedica plc: Oxford Biomedica - Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | finanznachrichten.deOxford BioMedica plc: Oxford Biomedica announces CFO transitionJuly 19, 2024 | finanznachrichten.de Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OXB Media Mentions By Week OXB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼0.000.54▲Average Medical News Sentiment OXB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼00▲OXB Articles Average Week Get the Latest News and Ratings for OXB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genus News Oxford Nanopore Technologies News Avacta Group News PureTech Health News Scancell News BTG News Faron Pharmaceuticals Oy News Bioventix News 4basebio News hVIVO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
